In vivo HSC gene therapy enables sustained eCD4-Ig expression for SIV prevention.
Li C, Anderson AK, Kuhlmann AS, Nelson V, Germond A, Wang H, Georgakopoulou A, Gil S, Martinez-Reyes J, Riker A, Raman SS, Kim J, Ng P, Palmer D, Alpert MD, Skamangas N, Bailey C, Ou T, Fennessey CM, Farzan M, Jerome KR, Keele BF, Kiem HP, Lieber A, Bui JK.
Li C, et al. Among authors: georgakopoulou a.
Mol Ther Adv. 2026 Feb 26;34(1):201683. doi: 10.1016/j.omta.2026.201683. eCollection 2026 Mar 12.
Mol Ther Adv. 2026.
PMID: 42137296
Free PMC article.